PHP
RMD icon

Parkman Healthcare Partners’s ResMed RMD Stock Holding History

Parkman Healthcare Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.43M Buy
+32,983
New +$6.84M 0.66% 50
2025
Q2 		– Sell
-22,622
Closed -$5.06M – 100
2025
Q1 		$5.06M Buy
+22,622
New +$5.28M 0.6% 49

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parkman Healthcare Partners's RMD Position: Q2 2026 in Review

Parkman Healthcare Partners opened a new position in ResMed (RMD) in Q2 2026: 32,983 shares worth $6.43M. The stake represents 0.66% of the portfolio and ranks #50 among its holdings. This is a return to the name: Parkman Healthcare Partners previously reported a position in RMD as recently as Q1 2025.

Parkman Healthcare Partners first reported a position in RMD in Q1 2025 and has held it in 2 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Parkman Healthcare Partners held 32,983 shares of ResMed worth $6.43M as of Q2 2026.
  • ResMed was a new Parkman Healthcare Partners position in Q2 2026.
  • ResMed made up 0.66% of Parkman Healthcare Partners's portfolio in Q2 2026, its #50 holding.
  • Parkman Healthcare Partners first reported a position in ResMed in Q1 2025 and has held it in 2 quarters since.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.